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Sonodynamic therapy (SDT) is an innovative anticancer approach where ultrasounds are used to trigger the cytotoxicity of
particular chemical compounds, known as sonosensitizers, which are per se harmless and ineffective alone. SDT takes
advantage of the non-thermal effect of the acoustic cavitation generated by selected pulsed or continuous ultrasounds. The
activated sonosensitizer then generates reactive oxygen species (ROS) leading to cancer cell death. Due to its non-
invasiveness, lack of systemic toxicity, the possibility of it being focused on target tissues and its ability to penetrate deeply
within the body, SDT has the potential to enhance cancer treatment, particularly for those solid tumours where surgical
removal is difficult even in the early stages. As the physical-chemical structure of the sonosensitizer is essential for the
success of SDT, the different aspects related to nanotechnology in medicine might well be able to enhance the triggering
effect ultrasounds have on sonosensitizing agents. This prompted us to investigate into the potential poly-methyl
methacrylate core-shell nanoparticles (NPs) loaded with meso-tetrakis (4-sulfonatophenyl) porphyrin (TPPS) have to
function as an innovative sonosensitizing system i.e. TPPS-NPs.
The anticancer efficacy of sonodynamic treatment with shock waves (SW), generated by a piezoelectric device and TPPS,
as a free or loaded nanoparticle formulation, was investigated on an in vitro and in vivo syngeneic cancer model.
Moreover, SW treatment, TPPS and NPs alone, or in combination was carried out as a control.
The in vitro effects of sonodynamic treatment were evaluated on cancer cell growth (monolayer cell culture and
multicellular tumour spheroids) and detailed investigation was also carried out on the mechanism of the sonodynamically-
induced cytotoxicity, studying the cell death mechanism by imaging, flow cytometry analyses, mRNA and protein
expression profiles.
The in vivo tumour volume changes after the sonodynamic treatment were assessed by magnetic resonance imaging (MRI)
and histopathologic analyses.
The in vitro porphyrin incorporation into living cells was significantly higher with TPPS-NPs than with free porphyrin. A
significant decrease in cancer cell growth was observed in two (p<0.001) and three dimensional (p<0.001) cell culture after
72 hours from the sonodynamic treatment with SW at an energy flux density of 0.43 mJ/mm2 for 500 impulses (4
impulses/sec) and TPPS-NPs (100 µg/ml), compared to control. The sonodynamic treatment with SW and TPPS-NPs
determined a significant increase (p<0.01) in the cell generation of ROS compared to cells exposed to the sonodynamic
treatment with SW and free TPPS. The uncontrolled increase in the generation of ROS after the sonodynamic treatment
with SW and TPPS-NPs led to cell damage i.e. the sonodynamic treatment was able to significantly increase apoptotic cell
death.
There was a statistically significant reduction in the volume of the tumor mass i.e. up to 50% for sonodynamic treatment
with SW and porphyrin loaded NPs, in a Mat B-III rat syngeneic breast cancer model when pre- and post-treatment
volumes were compared to sonodynamic treatment with SW and free porphyrin, at 72 hours. In conclusion, the porphyrin
properties were significantly enhanced once loaded onto NPs, due to an enhancement of the in vitro and in vivo anticancer
efficacy of the sonodynamic treatment.
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